Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 13, 2009, Pages 1326-1328

  Dahele, Max ^a,b   Brade, Anthony ^a,b   Pearson, Shannon ^a   Bezjak, Andrea ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; ERYTHEMA; FATIGUE; HUMAN; LUNG NON SMALL CELL CANCER; RADIATION DOSE; RIB FRACTURE; SHORT SURVEY; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; EVIDENCE BASED MEDICINE; LUNG TUMOR; METHODOLOGY; PATIENT SELECTION; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; REVIEW; STEREOTACTIC PROCEDURE; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; PATIENT SELECTION; RADIOTHERAPY; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 67650720527     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081291     Document Type: Review

References (9)

1. Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007;132:193-9.
2. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 2001;56:628-38.
3. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006;82:408-15, discussion 415-6.
4. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2(Suppl 3):S94-100.
5. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685-92.
6. Dahele M, Pearson S, Purdie T, et al. Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center. J Thorac Oncol 2008;3:1332-41.
7. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-9.
8. Lagerwaard FJ, van der Geld Y, Slotman BJ, et al. Quality of life after stereotactic radiotherapy for medically inoperable stage I lung cancer [abstract]. Int J Radiat Oncol Biol Phys 2006;66(Suppl 1):S133-4.
9. Ball D. Stereotactic radiotherapy for non small cell lung cancer. Curr Opin Pulm Med 2008;14:297-302.